Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Osteoporosis].

B Uebelhart1, R Rizzoli

  • 1Service des maladies osseuses, Centre collaborateur de l'OMS pour la prévention de l'ostéoporose, Département de rehabilitation et de gériatrie, Hôpitaux universitaires de Genève 1211 Genève 14. Brigitte.Uebelhart@hcuge.ch

Revue Medicale Suisse
|March 19, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next?

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

Re: Bobelyak M, Vaculik J, Stepan JJ. Bone mineral density assessment using Radiofrequency Echographic Mult Spectrometry (REMS) in patients before and after total hip replacement, Osteoporos Int 2025;https://doi.org/10.1007/s00198-025-07685-w and Re: Pocock N, Chan D. Editorial: Is REMS-BMD truly a measured parameter? A call for transparency and technical clarification, Osteoporos Int 2025;https://doi.org/10.1007/s00198-025-07699-4.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2025
Same author

Optimisation of vitamin D status in global populations.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2024
Same author

Comparing Prevalence of Sarcopenia Using Twelve Sarcopenia Definitions in a Large Multinational European Population of Community-Dwelling Older Adults.

The journal of nutrition, health & aging·2023
Same author

Effects of Vitamin D, Omega-3 Fatty Acids and a Home Exercise Program on Prevention of Pre-Frailty in Older Adults: The DO-HEALTH Randomized Clinical Trial.

The Journal of frailty & aging·2023
Same author

Prevalence of Physical Frailty: Results from the DO-HEALTH Study.

The Journal of frailty & aging·2022
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
See all related articles

Osteoporosis diagnosis relies on bone density scans, but bone quality and architecture are increasingly important. Fracture risk factors influence treatment thresholds for effective osteoporosis management.

Area of Science:

  • Orthopedics
  • Gerontology
  • Endocrinology

Context:

  • Osteoporosis diagnosis traditionally relies on bone mineral density (BMD) via DXA scans.
  • Emerging interest focuses on bone quality, particularly bone architecture, for a comprehensive assessment.
  • Fracture risk factors are increasingly used to refine diagnostic and therapeutic thresholds.

Purpose:

  • To explore the evolving diagnostic criteria for osteoporosis beyond BMD.
  • To review the impact of combined therapies on bone density and formation markers.
  • To summarize the efficacy of various osteoporosis treatments, including strontium ranelate, bisphosphonates, and Vitamin D.

Summary:

  • Bone quality and architecture are gaining importance in osteoporosis diagnosis, complementing BMD measurements.

Related Experiment Videos

  • Therapeutic strategies involving bone resorption inhibitors with teriparatide can affect bone formation markers and BMD gains.
  • Strontium ranelate demonstrates efficacy in reducing vertebral and non-vertebral fractures, while bisphosphonates offer rapid and long-term fracture prevention. Vitamin D effectively prevents falls.

    • Impact:

    • Highlights the shift towards a multifactorial approach in osteoporosis diagnosis and management.
    • Provides insights into the comparative efficacy of different osteoporosis pharmacotherapies.
    • Emphasizes the role of bone quality and architecture in predicting fracture risk and guiding treatment decisions.